Earnings PerformanceUHS reported Q3:25 adjusted EPS of $5.69, beating consensus estimates by +16%.
Revenue GrowthRevenue per adjusted admission in same-facility acute care increased 9.8% y/y, significantly ahead of the Street's expectation of 4.8%.
Stock Buyback ProgramThe company announced a $1.5bn increase to its stock repurchase program, increasing its aggregate available repurchase authorization to $1.759bn.